Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
147.95
+1.50 (+1.02%)
Official Closing Price
Updated: 4:15 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
May 24, 2024
Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024.
Via
InvestorPlace
Large Cap Biopharmaceuticals Performance
May 20, 2024
The biotech sector remains a laggard YTD as can be seen by the IBB.
Via
Talk Markets
For Biotech Stocks To Move Higher, This Must Move Lower
May 15, 2024
While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure.
Via
Talk Markets
Consumer Spending - Single Most Driving Force
May 07, 2024
The choices we make as consumers collectively shape the economic landscape, and our spending patterns influence the well-being of our communities and the nation.
Via
Talk Markets
Economic Modern Family-Tell Us a Story
May 05, 2024
Taking a look at the markets and how to best prepare for the coming week.
Via
Talk Markets
When Silver Looks Bad, It’s Been A Sign Of A Bottom
April 30, 2024
Silver cleared $26 but for only 3 weeks. Then it gapped lower in early May 2023 and did not clear that level ($26) again for a year.
Via
Talk Markets
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
April 30, 2024
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Can Semiconductors Pull Off Another Sustained Rally?
April 28, 2024
With all the news flying around, we have found incredible confidence in our trading strategies by following the technical picture.
Via
Talk Markets
Quick Look At The Economic Modern Family
April 23, 2024
While I am extremely focused on commodities as outlined in Monday’s Daily, my viewpoint for most equities remains cautious to neutral. What might turn us to be more bullish? Let’s analyze.
Via
Talk Markets
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.
Via
Talk Markets
Massive Weekly Price Consolidation Will Show The Way
April 08, 2024
Consolidation is one of our favorite chart patterns, especially when prices are consolidating at new highs or lows. The direction the price follows, up or down out of the consolidation can lead to...
Via
Talk Markets
Rangebound Major Secor ETFs - What’s Next?
April 04, 2024
Watching certain instruments for clues on the next moves, probably the best (equities) to watch is the major sector ETFs.
Via
Talk Markets
Topics
ETFs
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Healthcare And Biotech Stocks Review: Q1 2024 Performance
April 01, 2024
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
2 Top Biotech Buyout Candidates
March 31, 2024
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...
Via
Talk Markets
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
March 28, 2024
Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.
Via
InvestorPlace
Tuesday Talk: Big-Tech Under Attack
March 26, 2024
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.
Via
Talk Markets
Biotechnology And Healthcare, A Bit Of A Lull
March 25, 2024
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.
Via
Talk Markets
Healthcare And Biotech Update With Market At 2024 Highs
March 20, 2024
The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD.
Via
Talk Markets
3 Biotech ETFs Overdue for a Bounce
March 19, 2024
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.
Via
InvestorPlace
Topics
ETFs
Millionaire Makers: 3 Sectors Poised for 20X Gains
March 18, 2024
Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers.
Via
InvestorPlace
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.
Via
InvestorPlace
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
February 26, 2024
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.
Via
InvestorPlace
Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science
February 25, 2024
Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship.
Via
Talk Markets
Healthcare Stocks Are Looking Better But What About Biotech?
February 20, 2024
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.
Via
Talk Markets
Has The Solar ETF TAN Bottomed?
February 07, 2024
The last swing high before the huge parabolic move in TAN in 2020 was exactly where the current price was.
Via
Talk Markets
Topics
ETFs
The Transportation Sector Has A Story To Tell
February 05, 2024
With the market experiencing a dose of reality on interest rates, we still believe that current rates are not the worst news for the market, depending on where you look.
Via
Talk Markets
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
January 29, 2024
The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Top Thematic ETF Ideas For 2024
January 24, 2024
With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven.
Via
Talk Markets
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.